http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016051542-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e4f8ee304537f124cc9ae72b6401af6 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 |
filingDate | 2014-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7685aea868a83b7dc6a9c0215582779 |
publicationDate | 2016-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2016051542-A1 |
titleOfInvention | Methods of administration of single doses of vanoxerine to terminate acute episodes of cardiac arrhythmia |
abstract | Compositions and methods of treating patients suffering from symptoms of recent onset atrial fibrillation or atrial flutter comprising administration of a single dose of about 200 to about 400 mg of vanoxerine to return said patient to normal sinus rhythm in less than about 24 hours. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019147890-A1 |
priorityDate | 2013-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 325.